ADHD Treatment in Bipolar Disorder
Primary Recommendation
Stabilize bipolar symptoms FIRST with a mood stabilizer for a minimum of 3-6 months before initiating any ADHD medication; once mood is stable, add a low-dose stimulant (methylphenidate or mixed amphetamine salts) while maintaining the mood stabilizer. 1
Treatment Algorithm
Step 1: Achieve Complete Mood Stabilization
Absolute contraindications to stimulant use:
- Active manic or hypomanic episode with psychosis 1
- Concomitant MAO inhibitor use 1
- Unstable mood despite treatment 1
First-line mood stabilizers:
- Lithium (0.8-1.2 mEq/L for acute treatment, 0.6-1.0 mEq/L maintenance) 1, 2
- Valproate (therapeutic level 40-90 μg/mL) 1, 2
- Atypical antipsychotics (aripiprazole, risperidone, quetiapine, olanzapine) 1, 2
Required stability period: Maintain euthymic mood for 3-6 consecutive months before considering stimulants 1
Step 2: Initiate Low-Dose Stimulant Therapy
Preferred agents and starting doses:
- Methylphenidate: 5 mg once or twice daily 1
- Mixed amphetamine salts: 2.5 mg daily 1
- Lisdexamfetamine (Vyvanse): 20 mg daily 1
Titration schedule:
- Increase by 5 mg methylphenidate or 2.5 mg amphetamine weekly 1
- Monitor at each dose increase for mood destabilization 1
Evidence supporting this approach:
- Randomized controlled trials demonstrate that low-dose mixed amphetamine salts are safe and effective for comorbid ADHD once mood symptoms are stabilized 1
- Stimulant use does not affect relapse rates in bipolar youth properly stabilized on mood stabilizers 1
- Boys with ADHD plus manic-like symptoms responded as well to methylphenidate as those without manic symptoms, and stimulant treatment did not precipitate progression to bipolar disorder 1
Step 3: Intensive Monitoring Protocol
Initial phase (first 4-6 weeks):
- Weekly visits to assess ADHD symptom improvement 1
- Screen for warning signs of mania/hypomania at each visit: decreased need for sleep, increased energy or activity, racing thoughts or rapid speech, impulsive or risky behaviors, elevated or irritable mood 1
- Obtain ADHD rating scales from patient and collateral sources before each dose increase 1
- Monitor blood pressure, pulse, height, and weight 1
Maintenance phase:
Alternative Non-Stimulant Options
If stimulants are contraindicated or poorly tolerated:
- Atomoxetine: Screen for bipolar disorder before initiating; monitor for emergence of manic symptoms 3
- Bupropion: Must always be combined with mood stabilizer; lower risk of mood destabilization than SSRIs 1, 4
Important caveat: Atomoxetine FDA labeling specifically warns about screening patients for bipolar disorder before treatment, as it may induce mixed/manic episodes 3
Critical Pitfalls to Avoid
Never initiate stimulants before mood stabilization: This is the single most significant risk factor for inducing mania/hypomania 1
Do not confuse stimulant side effects with emerging bipolar symptoms: Behavioral activation from stimulants (motor restlessness, insomnia, impulsivity) can mimic hypomania but typically occurs early in treatment and is dose-related 1
Avoid antidepressant monotherapy: 58% of youth with bipolar disorder experienced emergence of manic symptoms after exposure to mood-elevating agents, most often antidepressants 1
Do not use tricyclic antidepressants: Although they have some efficacy for ADHD, they significantly increase risk of manic relapse 5
Special Considerations
If manic/hypomanic episode is currently present:
- Treat bipolar disorder aggressively first with mood stabilizer ± antipsychotic 6, 1
- Wait until complete remission of manic symptoms for minimum 3-6 months 1
- Only then consider adding stimulant 1
Comorbid substance abuse:
- Stimulants carry particular concern in adults with substance use disorders 6
- Consider atomoxetine or bupropion as safer alternatives 4
Maintenance therapy:
- Continue mood stabilizer for at least 12-24 months after achieving stability 1, 2
- Some patients require lifelong mood stabilizer treatment 1, 2
- Withdrawal of lithium dramatically increases relapse risk, especially within 6 months 1, 2
Psychosocial Interventions
Essential adjuncts to pharmacotherapy:
- Cognitive-behavioral therapy for both ADHD and mood symptoms 1
- Psychoeducation about symptoms, medication adherence, and early warning signs 1
- Family-focused therapy to enhance compliance and identify relapse triggers 1
These interventions improve outcomes beyond medication alone and should be incorporated from treatment initiation. 1